(Q97046475)
Statements
MATCH Treatment Subprotocol S2: Phase II Study of Trametinib in Patients With Tumors With GNAQ or GNA11 Mutations (English)
0 references
25 February 2016
0 references
16 May 2019
0 references
4
0 references
18 year
0 references